At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Targeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness Therapy (I-CAT)
In Brief
A clinical study evaluating I-CAT and Treatment as Usual for Schizophreniform Disorders. Completed, enrolled 38 participants across 4 sites.
Detailed Summary
To test the feasibility of a clinical trial implementing I-CAT, a novel therapeutic intervention combining strategies to improve stress reactivity and increase meaningful coping, as well as a range of possible proximal (e.g. autonomic, endocrine, immune indices of stress reactivity, symptom severity) and distal measures (function, relapse, quality of life) for 40 people with first episode psychosis in the context of a small randomized controlled trial.
Study Details
Timeline
Interventions
I-CAT is a novel therapeutic intervention combining mindfulness and meditation strategies to improve stress reactivity and increase meaningful coping, as well as a range of possible proximal (e.g. autonomic, endocrine, immune indices of stress reactivity, symptom severity) and distal measures (function, relapse, quality of life).
Treatment as usual defined by participant clinician at OASIS clinic.